Copyright
©The Author(s) 2021.
World J Gastroenterol. Feb 14, 2021; 27(6): 501-512
Published online Feb 14, 2021. doi: 10.3748/wjg.v27.i6.501
Published online Feb 14, 2021. doi: 10.3748/wjg.v27.i6.501
Figure 1 Receiver operating characteristic curves.
A: Carbohydrate antigen (CA) 19-9 + carcinoembryonic antigen; B: CA125; C: CA724; D: CA242; and E: Their combination in the diagnosis of advanced cystic mucinous neoplasms of the pancreas.
- Citation: Sun LQ, Peng LS, Guo JF, Jiang F, Cui F, Huang HJ, Jin ZD. Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas. World J Gastroenterol 2021; 27(6): 501-512
- URL: https://www.wjgnet.com/1007-9327/full/v27/i6/501.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i6.501